Insider Trading disclosures for HeartBeam Inc

The latest disclosure was made by Richard Ferrari in HeartBeam Inc where a trade of 29,412 Common Stock done at an average price of $1.7 was reported to US exchanges on Feb. 14, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Richard Ferrari	Director	Purchase of securities on an exchange or from another person at price $ 1.70 per share.	14 Feb 2025	29,412	179,136	-	1.7	50,000	Common Stock
Timothy Cruickshank	CFO	Purchase of securities on an exchange or from another person at price $ 1.70 per share.	25 Sep 2024	17,647	17,647	-	1.7	30,000	Common Stock
Timothy Cruickshank	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Sep 2024	400,000	400,000	-		-	Common Stock (right to buy)
George A. de Urioste	Director	Sale of securities on an exchange or to another person at price $ 2.34 per share.	06 Sep 2024	1,674	57,146	-	2.3	3,917	Common Stock
George A. de Urioste	Director	Sale of securities on an exchange or to another person at price $ 2.31 per share.	30 Aug 2024	5,500	58,820	-	2.3	12,705	Common Stock
George A. de Urioste	Director	Sale of securities on an exchange or to another person at price $ 2.26 per share.	27 Aug 2024	2,194	64,320	-	2.3	4,958	Common Stock
George A. de Urioste	Director	Sale of securities on an exchange or to another person at price $ 2.30 per share.	23 Aug 2024	2,500	66,814	-	2.3	5,750	Common Stock
George A. de Urioste	Director	Sale of securities on an exchange or to another person at price $ 2.38 per share.	23 Aug 2024	300	66,514	-	2.4	714	Common Stock
Kenneth Nelson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2024	33,185	127,147	-		0	Common Stock
Marga Ortigas-Wedekind	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2024	33,185	112,293	-		0	Common Stock
Mark Strome	Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2024	33,185	57,146	-		0	Common Stock
Richard Ferrari	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2024	44,247	149,724	-		0	Common Stock
George A. de Urioste	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2024	33,185	69,314	-		0	Common Stock
Willem Elfrink	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2024	33,185	317,982	-		0	Common Stock
Michael R. Jaff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2024	33,185	75,120	-		0	Common Stock
Marga Ortigas-Wedekind	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jul 2023	23,961	79,108	-		0	Common Stock
George A. de Urioste	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jul 2023	23,961	79,108	-		0	Common Stock
Mark Strome	Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jul 2023	23,961	23,961	-		0	Common Stock
Richard Ferrari	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jul 2023	31,948	105,477	-		0	Common Stock
Willem Elfrink	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jul 2023	23,961	284,797	-		0	Common Stock
Ken Nelson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jul 2023	23,961	93,962	-		0	Common Stock
Ken Persen	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Mar 2023	60,000	60,000	-		-	Stock option (right to buy)
Willem Elfrink	Director		12 Feb 2023	43,636	0	-		-	Common Stock warrant (right to buy)
Branislav Vajdic	CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2023	5,090	728	-		-	Common Stock Warrant (right to buy)
Branislav Vajdic	CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2023	1,287	911,391	-		0	Common Stock
Richard D. Brounstein	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2023	727	728	-		-	Common Stock Warrant (right to buy)
Richard D. Brounstein	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Feb 2023	184	112,108	-		0	Common Stock
Willem Elfrink	Director		09 Feb 2023	3,640	316,150	-	2.8	10,010	Common Stock
Willem Elfrink	Director		09 Feb 2023	3,640	0	-		-	Common Stock warrant (right to buy)
Willem Elfrink	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	09 Feb 2023	125,351	312,510	-		0	Common Stock
Richard D. Brounstein	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Dec 2022	760	0	-		-	Stock option (right to buy)
Richard D. Brounstein	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Dec 2022	760	111,924	-		0	Common Stock
Richard D. Brounstein	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Nov 2022	759	760	-		-	Stock option (right to buy)
Richard D. Brounstein	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Nov 2022	759	111,164	-		0	Common Stock
Richard D. Brounstein	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Oct 2022	760	1,519	-		-	Stock option (right to buy)
Richard D. Brounstein	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Oct 2022	760	110,405	-		0	Common Stock
Ken Persen	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Sep 2022	80,000	80,000	-		-	Stock option (right to buy)
Richard D. Brounstein	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Sep 2022	757	2,279	-		-	Stock option (right to buy)
Richard D. Brounstein	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Sep 2022	757	109,645	-		0	Common Stock
Richard D. Brounstein	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Aug 2022	757	3,036	-		-	Stock option (right to buy)
Richard D. Brounstein	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Aug 2022	757	108,888	-		0	Common Stock
Willem Elfrink	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2022	55,147	221,573	-		0	Common Stock
Richard Ferrari	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2022	73,529	73,529	-		0	Common Stock
George A. de Urioste	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2022	55,147	55,147	-		0	Common Stock
Marga Ortigas-Wedekind	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2022	55,147	55,147	-		0	Common Stock
Richard D. Brounstein	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jul 2022	757	108,131	-		0	Common Stock
Richard D. Brounstein	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jul 2022	757	3,793	-		-	Stock option (right to buy)
Willem Elfrink	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2022	50,000	50,000	-		-	Warrant (right to buy)
Jon Hunt	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	72,000	72,000	-		-	Stock option (right to buy)
Alan Baumel	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	38,000	38,000	-		-	Stock option (right to buy)

Showing 1 to 50 of 84 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

42.82% Fall from 52W High

High volume today

Insider Trading disclosures for HeartBeam Inc

The latest disclosure was made by Richard Ferrari in HeartBeam Inc where a trade of 29,412 Common Stock done at an average price of $1.7 was reported to US exchanges on Feb. 14, 2025.

Screeners based on Insider Trading and SAST parameters